Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Which index fund performed best this year? Review top performers, volatility, and potential shifts to inform your next move.
26,831 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
June’s stock market today saw Robinhood rise on the heels of an IPO underwriting announcement, signaling a potential ...
Federal Reserve Governor Michael S. Barr warns of a potential doomsday where many workers could be essentially unempl...
A sharp drop in Planet Labs shares sparked questions about growth, cash burn, and contract momentum. This guide break...
As Royal Gold prepares to share Q4 2025 results, investors should focus on streaming contracts, cash flow, and balanc...
A family emergency can spark quick decisions—and scammers count on that. This guide explains how a fake denver sherif...
Fuel prices could swing dramatically as geopolitical tensions in the Middle East escalate. Analysts warn the pump cou...
A forged $5,000 check can slip through a bank’s quick judgments, leaving the victim with bounced funds and a damaged ...
CrowdStrike has shown momentum, but the stock carries risk. Here’s why I’m skeptical and how investors can approach c...
Insider moves can reveal a lot about a company's near-term strategy, but they rarely tell the whole story. This guide...
A Goldman Sachs note presents a bullish scenario where gold could hit $5,400 per ounce. The outlook reverberates thro...